|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 92.56 EUR | +0.78% |
|
+4.19% | +3.13% |
| Apr. 29 | SANOFI : Jefferies reiterates its recommendation on the stock | CF |
| Apr. 29 | SANOFI : Deutsche Bank gives a Sell rating | ZD |
May 4 (Reuters) - Sanofi SA:
* EXEC ROMAN CHICZ SAYS EXPECT TO START GLOBAL LATE-STAGE STUDY OF COVID-19 VACCINE IN Q2; FILE REGULATORY SUBMISSIONS IN H2 2021- WORLD VACCINE CONGRESS 2021
* EXEC ROMAN CHICZ SAYS EXPECT RESULTS FROM NEW MID-STAGE STUDY FOR THE COVID-19 VACCINE IN A WEEK TO 10 DAYS- WORLD VACCINE CONGRESS 2021 Further company coverage:
| 1st Jan change | Capi. | |
|---|---|---|
| +3.13% | 123B | |
| +26.47% | 664B | |
| +30.38% | 567B | |
| -6.33% | 354B | |
| +19.35% | 330B | |
| +4.23% | 286B | |
| +14.40% | 234B | |
| +5.04% | 199B | |
| -10.02% | 196B | |
| -4.04% | 148B |
SANOFI 
